These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 8519018)
1. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure]. Hoyen HA; Alpert JS Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018 [No Abstract] [Full Text] [Related]
2. [ACE inhibitors in hypertension and heart failure]. Riegger AJ Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682 [No Abstract] [Full Text] [Related]
3. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers]. Pichler M; Klein W; Huber K; Pachinger O Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520 [TBL] [Abstract][Full Text] [Related]
4. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition]. Drexler H Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945 [No Abstract] [Full Text] [Related]
6. Angiotensin converting enzyme inhibitors. Pharmacological and physiological background for cardiovascular treatment. Jerie P Cor Vasa; 1992; 34(1):31-66. PubMed ID: 1288942 [No Abstract] [Full Text] [Related]
7. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease]. Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316 [No Abstract] [Full Text] [Related]
8. Hormones and hemodynamics in heart failure. Schrier RW; Abraham WT N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464 [No Abstract] [Full Text] [Related]
9. [Future aspects of therapy with diuretics]. Düsing R Internist (Berl); 1992 Aug; 33 Suppl 1():S53-6. PubMed ID: 1428699 [No Abstract] [Full Text] [Related]
10. [The clinical pharmacology of angiotensin II antagonists]. Arabidze GG; Novikova LS Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961 [TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system in hypertension: an update. Brunner HR Hosp Pract (Off Ed); 1990 Aug; 25(8):71-81. PubMed ID: 2116434 [TBL] [Abstract][Full Text] [Related]
12. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]. Schunkert H; Holmer SR; Riegger G Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057 [TBL] [Abstract][Full Text] [Related]
14. [What have we learned about inhibitors of the renin-angiotensin system?]. Waeber B; Nussberger J; Brunner HR Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients. Schneeweiss A Pediatr Cardiol; 1990 Oct; 11(4):199-207. PubMed ID: 2274447 [No Abstract] [Full Text] [Related]
16. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159 [TBL] [Abstract][Full Text] [Related]
17. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency]. Kolloch R; Offers E Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860 [No Abstract] [Full Text] [Related]